cd47 peptide-cloaked lipid nanoparticles promote cell-specific mrna delivery CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery - bota-peptide-serum cell CD47 Peptide-Cloaked Lipid Nanoparticles Promote Cell-Specific mRNA Delivery

bovine-hide-collagen-peptides-benefits The advancement of mRNA-based therapeutics delivered via lipid nano particles has revolutionized medicine, offering unprecedented potential for treating a wide array of diseases. However, achieving precise and efficient cell delivery remains a significant challenge. A groundbreaking development in this field is the creation of CD47 peptide-cloaked lipid nanoparticles that actively promote cell-specific mRNA delivery作者：X Xu·2025·被引用次数：1—CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery. Mol Ther, 33 (2025), pp. 3195-3208. Google Scholar. 213. R. Münter .... This innovative approach, detailed in research such as that by Papp et al., leverages the unique properties of CD47 peptide to enhance the targeted delivery of mRNA payloads2025年11月25日—mRNA-based therapeutics formulated inlipid nanoparticles(mRNA–LNPs) have emerged as a groundbreaking platform technology for vaccination, ....

Lipid nanoparticle technology has emerged as a leading platform for the mRNA delivery of genetic material.当使用SIRPα阻断抗体预处理细胞后，CD47/LNP-mRNA处理组的GFP表达部分恢复，MFI增加至13,032 RFU，表明CD47肽主要通过与SIRPα的相互作用来抑制巨噬细胞对LNP的摄取。 体内实验 ... These nanoparticles encapsulate fragile mRNA molecules, protecting them from degradation and facilitating their entry into target cells. The inherent challenge has been to direct these lipid nanoparticles specifically to desired cell populations while minimizing uptake by non-target cells, particularly phagocytic cells like macrophages.Tyler Ellis Papp's Post This is where the strategic incorporation of CD47 peptide into the lipid nanoparticle surface proves transformative.

The CD47 peptide, often referred to as the "don't eat me" signal, plays a crucial role in cellular communicationCD47 peptide-albumin cloaked mesoporous silica .... By cloaking lipid nanoparticles with this specific peptide, researchers are able to confer a crucial immune evasion propertyOur validated LNPdeliverysystem enables reliable genedeliveryto a range ofcelltypes—including Tcells, NKcells, macrophages, dendritic .... This modification significantly decreases uptake by macrophages and reduces non-specific uptake in organs such as the liver, both in vitro and in vivoCD47 peptide-cloaked lipid nanoparticles promote cell- .... This reduction in phagocytic clearance is essential for prolonging the circulation time of the nanoparticles and increasing the likelihood of them reaching their intended cellular destination.

The efficacy of this strategy is further underscored by research demonstrating functional protein expression in target cells, including primary human T cells, following delivery via lipid nanoparticles. The ability to achieve cell-specific mRNA delivery is paramount for maximizing therapeutic benefit and minimizing off-target side effects. The CD47 peptide-cloaked lipid nanoparticles represent a significant leap forward in achieving this specificity.2025年10月27日—mRNA-based therapeutics formulated inlipid nanoparticles(mRNA-LNPs) have emerged as a groundbreaking platform technology for vaccination, ... This technology is not limited to immune cells; the lipid nanoparticles are designed for delivering reporter DNA plasmid or mRNA into various cell types, indicating a broad applicability.

The implications of CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery extend to a multitude of applications. For instance, in the realm of cancer research, strategies are being developed that utilize a CD47-derived self-peptide to minimize macrophage clearance, thereby enhancing the therapeutic efficacy of mRNA-LNPs. Similarly, research into folate- and CD47-functionalized lipid nanoparticles aims to co-deliver specific payloads to pancreatic cancer cells, highlighting the versatility of this cloaking strategy.作者：TE Papp·被引用次数：19—Lipid nanoparticleencapsulating messenger RNA (LNP-mRNA) has emerged as a promising tool for therapeutic genedeliveryin applica- tions such ...

The development of these advanced lipid nanoparticles has been a collaborative effort, with scientists from institutions like Acuitas contributing to the understanding and refinement of mRNA-LNP platforms. The scientific community is actively exploring various modifications and ligand strategies, such as RGD peptide-based lipids for targeted mRNA delivery, to further optimize targeted delivery and gene editing applications. The ultimate goal is to create a reliable LNP delivery system for mRNA that enables precise gene therapy and vaccination approaches for a wide range of diseases. The continued exploration of cell-specific mRNA delivery via nanobody-functionalized or peptide-cloaked nanoparticles promises to unlock the full potential of mRNA-based therapeutics.ThisCD47/tLNP-mRNAplatform, with reduced phagocytic clearance, mitigated inflammatory effects, and enhanced targeteddelivery, could further facilitate the ...